Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07492355 · ClinicalTrials.gov registry record · Phase 1
TP-3654 Food Effect Study
A Phase 1 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT07492355 is a Phase 1 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 24 participants.
The verdict
NCT07492355, a Phase 1 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.
Interventions
- DRUG TP-3654
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2024-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07492355
The ClinicalTrials.gov registry entry for NCT07492355 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TP-3654 is the first listed.
NCT07492355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07492355 about?
NCT07492355 is a clinical study titled "TP-3654 Food Effect Study". This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.
What is the current status of trial NCT07492355?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2024-03-04. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT07492355?
The interventions under investigation include: TP-3654 (DRUG).
Who is sponsoring clinical trial NCT07492355?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.